Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Adolfo Rubinstein; Sebastián García Martí; Alberto Souto; Daniel Ferrante; Federico Augustovski

doi:10.1186/1478-7547-7-10

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Cost Effectiveness and Resource Allocation ◽

10.1186/1478-7547-7-10 ◽

2009 ◽

Vol 7 (1) ◽

pp. 10 ◽

Cited By ~ 34

Author(s):

Adolfo Rubinstein ◽

Sebastián García Martí ◽

Alberto Souto ◽

Daniel Ferrante ◽

Federico Augustovski

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Buenos Aires ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Generalized Cost

Download Full-text

PCV20 GENERALIZED COST-EFFECTIVENESS ANALYSIS OF PHARMACEUTICAL INTERVENTIONS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THAILAND

Value in Health ◽

10.1016/s1098-3015(11)73147-3 ◽

2010 ◽

Vol 13 (7) ◽

pp. A520

Author(s):

P Khonputsa ◽

JL Veerman ◽

M Bertram ◽

T Vos

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Generalized Cost ◽

Prevention Of Cardiovascular Disease ◽

Pharmaceutical Interventions

Download Full-text

Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand

Value in Health Regional Issues ◽

10.1016/j.vhri.2012.03.019 ◽

2012 ◽

Vol 1 (1) ◽

pp. 15-22 ◽

Cited By ~ 8

Author(s):

Panrasri Khonputsa ◽

Lennert J. Veerman ◽

Melanie Bertram ◽

Stephen S. Lim ◽

Nathorn Chaiyakunnaphruk ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Generalized Cost ◽

Prevention Of Cardiovascular Disease ◽

Pharmaceutical Interventions

Download Full-text

Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease

Journal of Medical Economics ◽

10.3111/13696998.2013.869500 ◽

2013 ◽

Vol 17 (2) ◽

pp. 132-141

Author(s):

Evangelos Hytopoulos ◽

Martin L. Lee ◽

Michael Beggs ◽

Cynthia French ◽

Kuo Bianchini Tong

Keyword(s):

Cardiovascular Disease ◽

Risk Assessment ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Next Generation ◽

Assessment Score ◽

Effectiveness Analysis

Download Full-text

A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease

Value in Health ◽

10.1016/j.jval.2017.08.040 ◽

2017 ◽

Vol 20 (9) ◽

pp. A404-A405

Author(s):

CN Kohli-Lynch ◽

K Boyd ◽

A Briggs ◽

C Delles

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Biomarker Testing ◽

The Cost

Download Full-text

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Diabetes Therapy ◽

10.1007/s13300-019-00701-3 ◽

2019 ◽

Vol 10 (6) ◽

pp. 2153-2167 ◽

Cited By ~ 7

Author(s):

Mafalda Ramos ◽

Volker Foos ◽

Anastasia Ustyugova ◽

Nikco Hau ◽

Pranav Gandhi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Effectiveness Analysis

Download Full-text

A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?

Genetics in Medicine ◽

10.1038/s41436-020-00995-w ◽

2020 ◽

Author(s):

Ye Zhu ◽

James P. Moriarty ◽

Kristi M. Swanson ◽

Paul Y. Takahashi ◽

Suzette J. Bielinski ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Disease Management ◽

Cost Effectiveness Analysis ◽

Model Based ◽

Panel Testing ◽

Effectiveness Analysis

Download Full-text

Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis

Cost Effectiveness and Resource Allocation ◽

10.1186/1478-7547-8-2 ◽

2010 ◽

Vol 8 (1) ◽

pp. 2 ◽

Cited By ~ 11

Author(s):

Gary M Ginsberg ◽

Stephen S Lim ◽

Jeremy A Lauer ◽

Benjamin P Johns ◽

Cecilia R Sepulveda

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Generalized Cost

Download Full-text

Development of WHO guidelines on generalized cost-effectiveness analysis

Health Economics ◽

10.1002/(sici)1099-1050(200004)9:3<235::aid-hec502>3.0.co;2-o ◽

2000 ◽

Vol 9 (3) ◽

pp. 235-251 ◽

Cited By ~ 246

Author(s):

Christopher J.L. Murray ◽

David B. Evans ◽

Arnab Acharya ◽

Rob M.P.M. Baltussen

Keyword(s):

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Who Guidelines ◽

Effectiveness Analysis ◽

Generalized Cost

Download Full-text

PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES

Value in Health ◽

10.1016/s1098-3015(10)67445-1 ◽

2005 ◽

Vol 8 (6) ◽

pp. A98-A99

Author(s):

M Lamotte ◽

L Annemans ◽

T Evers ◽

M Kubin

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Primary Prevention ◽

Low Dose ◽

Cost Effectiveness Analysis ◽

European Countries ◽

Dose Aspirin ◽

Effectiveness Analysis ◽

Low Dose Aspirin ◽

Prevention Of Cardiovascular Disease

Download Full-text

Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-016-0059-y ◽

2016 ◽

Vol 14 (1) ◽

Cited By ~ 12

Author(s):

Mieraf Taddesse Tolla ◽

Ole Frithjof Norheim ◽

Solomon Tessema Memirie ◽

Senbeta Guteta Abdisa ◽

Awel Ababulgu ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Prevention And Treatment

Download Full-text